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Radiofrequency ablation is routinely used to target numerous cardiac arrhythmias, such as ventricular 
tachycardia and atrial fibrillation.1,2 In many of these pro-
cedures, the goal of the ablation procedure is to electrically 
isolate one region of the myocardium from another.3 When 
ablating for atrial fibrillation, the goal is to achieve elec-
tric isolation of the pulmonary veins.4 Yet, despite the best 
efforts, the success rate for some ablation procedures like 
those for atrial fibrillation ranges from 40% to 80%.5,6 One 
of the reasons for the low procedural success is the pres-
ence of gaps in ablation lesion sets.7–9 In the current ablation 
procedures, there is no direct visualization of changes in the 
tissue, and ablation is inferred based on numerous indirect 
parameters, such as local electrogram attenuation, power 
delivered, and temperature at the catheter tip. None of these 
are completely reliable measures of ablation and can result 
in ablation lesions sets with gaps.
Magnetic resonance imaging (MRI) has excellent soft tissue 
visualization capability, which can be used to identify ablation 
lesions.10,11 Here, we report using MRI to acutely identify 
ablation lesions and accurately determine gaps in ablation 
lesion sets. We then describe using a real time MRI system 
to acutely target and ablate these gap areas in the ablation 
lesion set. In addition, we characterize the smallest gaps that 
can be identified using the real-time MRI system. A method 
to identify ablation lesions and gaps in between them and the 
ability to target these gaps acutely can potentially result in 
significant improvement in the outcome of these procedures.
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Methods
Animal Preparation
A swine model was used for the study. The Institutional Animal 
Care and Use Committee approved the study. Animals weighing 30 
to 35 kg (n=12) were used and were given a preanesthetic cocktail 
of telazol 4.4 mg/kg, ketamine 2.2 mg/kg, and xylazine 2.2 mg/kg in-
tramuscularly. For anesthesia, 20 to 40 minutes later they were given 
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Background—Radiofrequency ablation is routinely used to treat cardiac arrhythmias, but gaps remain in ablation lesion sets 
because there is no direct visualization of ablation-related changes. In this study, we acutely identify and target gaps using 
a real-time magnetic resonance imaging (RT-MRI) system, leading to a complete and transmural ablation in the atrium.
Methods and Results—A swine model was used for these studies (n=12). Ablation lesions with a gap were created in the 
atrium using fluoroscopy and an electroanatomic system in the first group (n=5). The animal was then moved to a 3-tesla 
MRI system where high-resolution late gadolinium enhancement MRI was used to identify the gap. Using an RT-MRI 
catheter navigation and visualization system, the gap area was ablated in the MR scanner. In a second group (n=7), 
ablation lesions with varying gaps in between were created under RT-MRI guidance, and gap lengths determined using 
late gadolinium enhancement MR images were correlated with gap length measured from gross pathology. Gaps up to 
1.0 mm were identified using gross pathology, and gaps up to 1.4 mm were identified using late gadolinium enhancement 
MRI. Using an RT-MRI system with active catheter navigation gaps can be targeted acutely, leading to lesion sets with no 
gaps. The correlation coefficient (R2) between the gap length was identified using MRI, and the gross pathology was 0.95.
Conclusions—RT-MRI system can be used to identify and acutely target gaps in atrial ablation lesion sets. Acute targeting 
of gaps in ablation lesion sets can potentially lead to significant improvement in clinical outcomes. (Circ Arrhythm 
Electrophysiol. 2012;5:1130-1135.)
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20 to 60 mg/kg of pentobarbital intravenously. They were main-
tained in deep anesthesia by giving periodic intravenous injections 
of 30 to 40 mg/kg of pentobarbital. The animals were mechanically 
ventilated. Venous access to the femoral veins and femoral artery 
was obtained by a cut-down approach to the blood vessels. Sheaths 
of 11F (St Jude Medical, Austin, TX) were placed in the right and 
left femoral vein and were used to insert the mapping and ablation 
catheter. A 6F sheath was placed in the right femoral artery and was 
used for blood pressure monitoring and for obtaining periodic ar-
terial sample for arterial blood gas analysis during the study. Two 
groups of animals were used for the study. After being anesthetized, 
the animals in the first group (n=5) were taken to the electrophysi-
ology laboratory with a fluoroscopy system, and ablation lesions 
were created as described below. The animals in the second group 
(n=7) were taken directly to the real-time MRI (RT-MRI) system 
after being anesthetized for ablation and identification of the gap as 
described in the section Visualizing Gap Between Ablation Lesions 
Using MRI.
Electrophysiology Studies Using Fluoroscopy
Anesthetized animal from the first group (n=5) was moved to the 
electrophysiology laboratory with a fluoroscopy (Artis Zeego; 
Siemens USA, Malvern, PA) and an electroanatomic mapping sys-
tem. CARTO (Biosense Webster, Diamond Bar, CA) electroana-
tomic mapping system was used for electrophysiology studies. A 
nonirrigated 4-mm-tip NaviStar (Biosense Webster) catheter was 
used for electroanatomic mapping. The catheter was advanced to the 
right atrium (RA) via the sheath in the right femoral vein. A baseline 
voltage map of the RA was made. Two discrete ablation lesions were 
made in the RA spaced about a centimeter apart. Ablation was done 
in a temperature-controlled mode with a 60° cut-off and a power of 
30 W for 30 seconds. After the ablation, a new voltage map was cre-
ated to confirm the low-voltage areas in the ablated areas and normal 
voltage in the gap in between. After the electrophysiology study, the 
NaviStar catheter was removed and the animal was checked to make 
sure it was free of any ferromagnetic materials. It was then moved 
to the MR scanner.
Electrophysiology Study in the MRI Scanner
After the ablation in the fluoroscopy suite, the animal was moved 
to the MRI suite with a 3-tesla MRI scanner (Verio; Siemens 
Healthcare, Erlangen, Germany). MRI-compatible ECG electrodes 
were put on the chest and connected to an MRI-compatible moni-
toring system (Veris MR; Medrad Inc, Warrendale, PA) for ECG, 
blood pressure, and oxygen saturation monitoring. The total time 
from the end of ablation in the fluoroscopy suite to the beginning 
of MR image acquisition was less than an hour. A gadolinium-based 
MRI contrast agent (Multihance; Bracco Diagnostic Inc, Princeton, 
NJ) was injected, and magnetic resonance angiogram (MRA) of the 
whole heart was acquired. MRA was performed during slow infusion 
of gadolinium-based contrast agent (dose=0.15 mmol/kg; infusion 
rate=0.1 mmol/s; Multihance; Bracco Diagnostic Inc). MRA images 
were acquired using a 3-dimensional (3D) respiratory navigated and 
ECG-gated gradient-recalled echo pulse sequence, with echo time/
repetition time of 1.3/2.9 ms, flip angle of 23°, bandwidth of 870 
Hz/pixel, field of view (FOV) of 240 × 240 × 120 mm, matrix size of 
192 × 192 × 48, 25% oversampling in slice-encoding direction, voxel 
size of 1.25 × 1.25 × 2.5 mm, and phase-encoding direction of left to 
right. The data acquisition was limited to 20% of cardiac cycle and 
was performed during the stationary (diastolic) phase of RA. Twenty 
minutes after contrast injection, late gadolinium enhancement (LGE) 
images with spatial resolution of 1.25 × 1.25 × 2.5 mm were acquired. 
The LGE images were acquired using a 3D respiratory-navigated, 
inversion recovery–prepared gradient-recalled echo pulse sequence 
with echo time of 1.4 ms, repetition time of 3.1 ms, flip angle of 14°, 
bandwidth of 780 Hz/pixel, FOV of 240 × 240 × 110 mm, matrix size 
of 192 × 192 × 40, 10% oversampling in slice-encoding direction, 
voxel size of 1.25 × 1.25 × 2.5 mm, and phase-encoding direction of 
left to right. Inversion pulse was applied to every heart beat, and fat 
saturation was applied immediately before data acquisition. Timing 
for data acquisition was found from cine images of RA. The data 
acquisition was limited to 15% of cardiac cycle and was performed 
during the stationary phase of RA.
The RA geometry was segmented from the MRA image volume 
using Seg3D 2.0 (Scientific and Computing Institute, University of 
Utah). Specifically, the contrast-enhanced blood pool was isolated 
using a user-defined threshold. A surface mesh of the RA was then 
generated from the segmentation using SCIRun 4.6 (Scientific and 
Computing Institute, University of Utah). The ablation lesions were 
observed and segmented from the LGE-MRI scan using Seg3D 2.0 
based on acute contrast enhancement. Geometric models of the le-
sions were then created using SCIRun 4.6 and imported concurrently 
with the MRA-derived RA model in the real-time MRI visualization 
and navigation interface interactive front end (Siemens Corporate 
Research, Princeton, NJ). RT-MRI guidance of the catheter move-
ment during mapping and ablation was provided by the interactive 
real-time tip tracking pulse sequence and the interactive front end 
navigation and visualization software (Siemens Corporate Research, 
Princeton, NJ). The catheter was visualized during navigation with 
an RT-MRI sequence (radiofrequency-spoiled gradient-recalled echo 
pulse sequence with a frame rate of ≈5 frames per second), and 4 
tracking microcoils near the tip of the custom MRI-compatible cath-
eter (MRI Interventions Inc, Irvine, CA) allowed for accurate de-
tection of the catheter position in 3D space. Real-time images were 
acquired sequentially in multiple slices and rendered in 3D at their 
respective locations. Typical scan parameters for RT sequence were 
as follows: echo time, 1.5 ms; repetition time, 3.3 ms; flip angle, 13°; 
bandwidth, 750 Hz/pixel; spatial resolution, 1.8 × 2.0 mm; and slice 
thickness, 5 mm.
An 8F, 3-tesla MR-compatible, irrigated, temperature sensing, 
mapping, and ablation catheter (MRI Interventions, Irvine, CA), de-
scribed earlier,12 was inserted into the RA via the right femoral vein. 
The RT-MRI visualization interface with the shell of the RA was used 
to guide the catheter movement, along with the surface ECG and in-
tracardiac electrograms recorded by the catheter. The tip of the cath-
eter was positioned on the more cranial lesion, and under RT-MRI 
guidance the gap area between the 2 lesions was ablated. The MRI-
compatible catheter was connected to a standard radiofrequency abla-
tion unit (Stockert-70, radiofrequency generator; Biosense Webster) 
with custom-built interface for the MRI-compatible catheters. A 
power setting of 30 W was used to ablate in the atrium. After ablation 
in the MR scanner, gadolinium contrast agent was infused again and 
LGE images were acquired. After imaging, the animals were injected 
with triphenyltetrazolium chloride and the animals were euthanized 
with intravenous potassium chloride. Triphenyltetrazolium chloride 
stains live tissue red in color, clearly demarcating ablated and infarct-
ed areas.13,14 The animal chest was opened and the heart excised for 
further examination. The endocardial surface of the RA was exposed 
by making a linear incision from the inferior to the superior vena 
cava. The ablated lesions were visually inspected, and tissues were 
excised for histology.
Visualizing Gap Between Ablation Lesions  
Using MRI
For this part of the project, the second set of animals (n=7) were 
prepared as described above, except that instead of making lesions 
in the fluoroscopy suite, the animals were taken directly to the MRI 
scanner. MRA was acquired using a gadolinium-based contrast agent, 
as described above. From the MRA images, the RA was segmented 
and meshed (using Seg3D 2.0 and SCIRun 4.6, respectively) and 
imported in the real-time catheter visualization software interface. 
MRI-compatible catheter described above was inserted in the right 
femoral vein and advanced to the RA using RT-MRI guidance. Using 
the segmented shell of the RA and with RT-MRI guidance, discrete 
ablation lesions were made in the RA. To minimize the number 
of animals, paired lesions with varying gaps between the ablation 
lesions were made in distinct parts of the RA. These lesions were 
made in the temperature-controlled mode set at 60° and 30 W. The 
ablation was carried out for 30 seconds. After the lesions were made, 
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3D LGE MR images were acquired. The LGE images had a spatial 
resolution of 1.0 × 1.0 × 1.5 mm. Subsequently, triphenyltetrazolium 
chloride was injected, and the animal was euthanized using 
intravenous potassium chloride. The chest was opened and the heart 
excised for further examination. The gap between the lesions was 
measured on the endocardial surface. Eight of the ablated lesion 
pairs with the gap in between underwent hematoxylin and eosin and 
Masson trichrome staining to further characterize the gap and the 
ablated areas. For histology, the tissue was fixed in formalin and 
then embedded in a paraffin block. Once embedded in the block, 
sections were obtained and stained with hematoxylin and eosin and 
Masson trichrome. The 3D LGE MR images were processed using 
Osirix (Osirix Imaging Software, Pixmeo, Geneva, Switzerland). A 
higher-resolution 3D data set with a resolution of 0.5 × 0.5 × 1.0 mm 
was created by interpolating the data. The 3D image set was 
visualized using the 3D multiplanar reconstruction technique. The 
measurement tool was used to quantify the gap length between the 
ablation lesions.
Statistical Analysis
The gap length between the ablation lesions determined from the 
endocardial surface of gross pathology was correlated with the gap 
length determined from the 3D LGE MR images. The correlation co-
efficient was determined for the 2 measurements.
Results
Filing the Gap Using Real-Time MRI
At baseline, none of the animals showed any areas of low 
voltage in the RA. After obtaining a baseline voltage map, 2 
discrete ablation lesions were made in the RA. The new volt-
age map created after the lesions showed discrete areas of low 
voltage at the ablation sites and normal voltage in the gap area 
between the lesions (online-only Data Supplement Figure I).
After creating the ablation lesions in the fluoroscopy suite, 
the animal was moved to the MR scanner. In the MR scanner, 
MRA and LGE images were acquired identifying the ablation 
lesions. Figure 1 depicts LGE images showing the 2 discrete 
lesions in the RA in the axial (A and B), coronal (C), and 
sagittal (D) planes. The MRA and LGE images were seg-
mented to create a shell of the RA and identify ablated lesions 
with the gap in between. This image was uploaded in the real-
time MRI visualization and navigation interface at the MR 
scanner. Figure 2 is a screen shot of the real-time navigation 
system in the MRI, showing the RA shell, the ablated lesions, 
and the catheter in between. The real-time navigation system 
was used to position the catheter at the previously ablated 
areas and guide its navigation to ablate the gap between the 
2 lesions. In addition to using the RA shell, the location of 
the previously ablated lesions on the shell and real-time MR 
images through different planes and the lack of local bipolar 
electrogram were used to confirm the location of previously 
ablated areas. After ablating the gap area, the LGE images 
were reacquired, confirming that the gap between the previ-
ously ablated lesions was also ablated. Figure 3 illustrates 
LGE images with the gap area between the lesions ablated in 
axial (A and B), coronal (C), and sagittal (D) planes.
Gross Pathology and Histology
The RA tissue around the ablated area was excised for 
gross examination and histological examination. On gross 
examination, a continuous set of lesions was confirmed. Cut 
sections on gross pathology and Masson trichrome staining 
confirmed the ablation and its transmurality (online-only Data 
Supplement Figure II).
Minimum Gap Length Detected by MRI
Ablation lesions with varying distance between them were 
made in the RA. The gap length as measured in the endocar-
dial surface was compared with the gap length as measured 
Figure 1. A and B, Axial late gadolinium enhancement cardiac 
magnetic resonance images showing the 2 ablation lesions in the 
posterior wall of the right atrium. A is more cranial of the 2 axial 
planes. C, A coronal section showing both the lesions. D, A sag-
ittal section showing the 2 lesions. The cranial lesion is marked 
by a blue arrow and the caudal lesion is marked by a green 
arrow.
Figure 2. Screen shot of the real-time magnetic resonance imag-
ing navigation system. On the left are 3 magnetic resonance 
images in 3 perpendicular planes. The location of these planes 
can be adjusted by the user for optimal performance. Right, A 
sagittal viewing plane with the shell of the right atrium (in orange) 
and the ablated lesions (marked in purple with blue and green 
arrows) imported to the real-time catheter navigation interface. 
In this image, the catheter tip is in the gap area between the 2 
ablation lesions.
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in the 3D LGE MR image set. Figure 4 shows a typical MR 
image of a pair of ablation lesion with the gap in between. 
Figure 4A and 4B represents perpendicular planes through 
the same pair of lesions in the RA. Figure 4C and 4D repre-
sents magnified images shown in panels A and B, with the 
gap between the lesions marked using the measurement tool 
in Osirix.
The gap length as determined by the gross pathology 
(online-only Data Supplement Figure III) was correlated with 
the gap length determined in the LGE MR images. Figure 5 
shows the correlation between the gap length as determined 
by MRI, with the gap length determined by gross pathology. 
The correlation coefficient (R2) is 0.95.
Discussion
Currently, when ablating for atrial fibrillation, the goal is to 
achieve electric isolation of all the pulmonary veins.4 Hence, 
when ablating and after making the initial set of ablation 
lesions, the electric isolation of the pulmonary vein is checked 
using a functional assay typically using a multipole lasso cath-
eter. If the veins are not electrically isolated, the lasso catheter 
is used to guide further ablation to isolate the veins. Using the 
lasso catheter allows to assess gaps that are electrically active 
and conducting, but it provides no feedback on the changes 
from ablation in the myocardial tissue itself. Furthermore, 
with the use of lasso catheter, one cannot identify gaps if they 
are electrically silent, and electric isolation has been achieved 
despite the presence of gaps. Other techniques such as pacing 
from the ablation line to capture the surrounding tissue have 
been reported to assess for completeness of ablation.15 Despite 
the use of these tests to eliminate gaps in ablation lesion sets, 
pulmonary vein reconnection continues to occur over time.
In numerous studies when patients were brought back 
for redo procedures because of arrhythmia recurrence, the 
pulmonary veins isolated at the index procedures were no 
more electrically isolated.7,16 The time course of recovery 
of conduction across previously isolated pulmonary veins 
is quite variable. In a human study, within just an hour after 
completing the pulmonary vein isolation, it was found that 
30% of the pulmonary veins were reconnected.17 Reisolating 
these veins resulted in an improvement in the outcome, with 
a lower recurrence rate for atrial fibrillation.17 In an animal 
study, looking at changes in the action potential duration 
as a result of ablation, it was found that acutely there was a 
gradation in action potential changes, with the largest change 
occurring at the boundary of the ablated region. The action 
Figure 3. Late gadolinium enhancement magnetic resonance 
(MR) images acquired after ablating the gap between prior abla-
tion lesions. A and B, Axial planes through the cranial (A) and 
caudal (B) ablation lesions. C, A coronal section showing that the 
gap area between the 2 lesions is also ablated (marked by red 
arrow). D, A sagittal section showing the continuous ablation 
line. The lesions made in the electrophysiology laboratory using 
fluoroscopy are marked by blue and green arrows, and the gap 
area ablated in the MR scanner using the real-time MR system is 
marked with red arrow.
Figure 4. Late gadolinium enhancement cardiac magnetic 
resonance images showing ablation lesions with gap between 
them. A and B, Perpendicular planes showing the same ablation 
lesions in the right atrial wall. The ablation lesions are marked 
by black arrows. C and D, Magnified areas with the ablation 
lesions shown in A and B, respectively. The gap length between 
the lesions measured using the measurement tool in Osirix was 
1.8 mm and is shown in C and D.
Figure 5. Correlation between gap length determined by gross 
pathology vs magnetic resonance imaging (MRI).
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potential duration gradually approached normal ≈3 mm away 
from the ablation margin.18 After about just a week, the action 
potential had recovered completely all the way to the edge of 
the ablated area.18
It has also been shown in an animal study that one can 
have electric isolation, despite the presence of gaps in myo-
cardial tissue.19 Using the current assay of a lasso catheter 
to identify and acutely target any gap areas, we miss these 
electrically silent gaps. Furthermore, it has been shown in a 
computational model that gaps, which might not be conduct-
ing acutely, can start conducting, with the recovery of some 
conductivity potentially leading to arrhythmia recurrence.19 
As a result, using only electric conductivity as an end point 
for isolation is not enough to have long-term electric isola-
tion. To make the electric isolation more permanent, there 
is a need for direct visualization of changes at the tissue 
level from ablation and identification of gaps in the ablation 
lesion sets. MRI has excellent soft tissue visualization char-
acteristics and has been used to identify ablated areas,20 and 
effort has been made to develop MRI-based electrophysiol-
ogy ablation system.12,21 Here, for the first time we have used 
MRI to accurately identify gaps in ablation lesions imme-
diately after ablation and then target them acutely using 
real-time catheter visualization. Although few other groups 
have attempted developing a real-time MRI system, apply-
ing it to acutely identify and target gaps in ablation lesions is 
novel and to the best of our knowledge has not been reported 
before.22,23 This acute targeting of gaps in lesion sets will 
lead to more robust electric isolation by creating lesion sets 
without any gaps.
In conclusion, we have used the excellent soft tissue visual-
ization capabilities of MRI to accurately identify gaps in abla-
tion lesion sets and, then, using a real-time MRI system have 
shown that these gaps can be targeted acutely. This can lead 
to more robust ablation lesions, potentially improving clinical 
outcomes over time.
Limitations
The resolution of the gaps that can be detected by MRI in 
this study was in the millimeter range. Although submillime-
ter gaps are within the limits of gaps that can be tolerated in 
certain situations as predicted by computational models, a 
higher resolution will likely lead to better results.19 This can 
be achieved with higher-resolution scans requiring further 
improvement in technology and longer scan times.
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CLINICAL PERSPECTIVE
The goal in most ablation procedures is to electrically isolate one region from another by creating a set of contiguous and 
transmural ablation lesions. Yet, despite the best effort of electrophysiologists, gaps remain in ablation lesion sets. This 
stems from the fact that when ablating there is no direct visualization of ablation-related tissue changes and ablation is 
inferred based on numerous indirect parameters. Magnetic resonance imaging (MRI) has excellent soft tissue visualization 
characteristics, and in this study, this property of MRI was used to acutely identify ablation lesions and in turn identify the 
gaps between ablation lesions. A challenge in using MRI for ablation is that the currently used ablation catheters are not MRI 
compatible. For this study, MRI-compatible electrophysiology mapping and ablation catheters were developed. A complete 
real-time MRI-based electrophysiology system was also developed by integrating the use of MRI-compatible catheters with 
real-time imaging. This system was used to acutely identify the ablation lesions, the gaps in between the lesions, and then 
target the gaps acutely. An MRI-based electrophysiology system not only does away with exposure of ionizing radiation 
to the patient and the operator but also allows direct visualization of tissue changes, with ablation potentially leading to 
significant improvement in ablation procedure outcomes.
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  SUPPLEMENTAL	  MATERIAL	  	  	   	  
	  	  
	  	  CARTO	  voltage	  map	  made	  before	  and	  after	  creating	  lesions	  in	  the	  posterior	  wall	  of	  the	  right	  atrium.	  Panel	  A	  is	  a	  baseline	  bipolar	  voltage	  map	  of	  the	  right	  atrium	  showing	  no	  areas	  of	  low	  voltage.	  A	  PA	  view	  of	  the	  right	  atrium	  is	  shown.	  Panel	  B	  is	  a	  voltage	  map	  made	  after	  two	  discrete	  ablation	  lesions.	  The	  ablated	  area	  is	  marked	  by	  red	  dots.	  The	  voltage	  map	  confirms	  areas	  of	  low	  voltage	  around	  the	  ablation	  lesions.	  The	  bi-­‐polar	  voltage	  color	  scale	  is	  shown	  on	  the	  top	  right	  hand	  corner	  of	  panels	  A	  and	  B.	  	  	  	   	  
	  	  	  Gross	  pathology	  and	  histology	  of	  right	  atrial	  tissue	  showing	  ablation	  lesions	  after	  the	  gap	  area	  was	  ablated	  in	  the	  MR	  scanner.	  Panel	  A	  is	  gross	  tissue	  specimen	  showing	  the	  two	  lesions	  made	  in	  the	  EP	  lab	  using	  fluoroscopy	  (blue	  and	  green	  arrows)	  and	  the	  gap	  area	  ablated	  in	  the	  MR	  scanner	  (red	  arrow).	  	  The	  yellow	  line	  in	  panel	  A	  is	  the	  plane	  of	  cut	  section	  shown	  in	  panel	  B.	  Panel	  B	  is	  a	  cut	  section	  through	  the	  ablation	  lesions	  showing	  the	  transmurality	  of	  the	  lesions.	  Endo	  and	  epi	  mark	  the	  endocardial	  and	  the	  epicardial	  surfaces	  of	  the	  tissue	  specimen.	  Panel	  C	  is	  a	  Masson’s	  Tichrome	  stained	  tissue	  specimen	  from	  panel	  B	  showing	  the	  lack	  of	  any	  red	  stained	  areas	  in	  the	  middle	  of	  the	  section	  confirming	  the	  transmurality	  of	  the	  ablation	  lesions.	  	  	   	  
	  	   	  Gross	  pathology	  and	  histology	  of	  atrial	  tissue	  showing	  ablation	  lesions	  with	  gaps	  of	  varying	  lengths.	  Panel	  A	  shows	  ablation	  lesions	  (marked	  by	  arrowheads)	  made	  in	  the	  right	  atrium	  spaced	  1	  to	  4	  mm	  apart.	  Panel	  B	  is	  a	  gross	  tissue	  section	  with	  two	  ablation	  lesions	  and	  a	  gap	  of	  1	  mm	  from	  another	  animal.	  Panel	  C	  is	  tissue	  shown	  in	  panel	  B	  stained	  with	  Masson’s	  Trichrome	  confirming	  the	  ablation	  lesion	  and	  the	  1	  mm	  gap	  in	  between.	  Panel	  D	  is	  another	  section	  from	  the	  same	  block	  as	  in	  C	  confirming	  the	  transmurality	  of	  the	  left	  sided	  lesion.	  	  	   	  
